Therapeutic agent

Hyperbaric Oxygen Therapy (HBOT)

ModerateEvidence level
5Registered trials
2Conditions
0Study references

Evidence Summary

Evidence Level
Moderate
Mechanism
Enrollment: Actual, Enrollment: Estimated, Sponsor Type: Other, Sponsor Type: Other Gov
Safety
Limited specific safety data in these populations. Review full prescribing information and consult specialist. Many agents used off-label or investigational.
Dosing
See linked studies/trials for reported doses and durations; typical protocols vary widely.
Investigational for listed conditions. 5 associated trial(s) and 0 study reference(s) in current data. Review primary sources and consult specialists before use.

Clinical Trials

5 trial(s) registered

NCT IDTitlePhaseStatus
NCT06452095Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy for the Treatment of PNot applicableRecruiting
NCT04842448Safety and Efficacy of Hyperbaric Oxygen Therapy for Long COVID SyndromePhase 2Completed
NCT06267300Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled TrialPhase 3Unknown status
NCT04905888Hyperbaric Oxygen for Long COVID-19 Pulmonary SequelaPhase 2Withdrawn
NCT07621068Hyperbaric Oxygen Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)Not applicableRecruiting

Key Studies / References

  • See linked studies